- Home
- LUCY vs CELZ Comparison
LUCY vs CELZ Comparison
Compare LUCY & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- CELZ
- Stock Information
- Founded
- LUCY 2017
- CELZ 1998
- Country
- LUCY United States
- CELZ United States
- Employees
- LUCY N/A
- CELZ N/A
- Industry
- LUCY Ophthalmic Goods
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- LUCY Health Care
- CELZ Health Care
- Exchange
- LUCY Nasdaq
- CELZ Nasdaq
- Market Cap
- LUCY 8.9M
- CELZ 7.4M
- IPO Year
- LUCY 2022
- CELZ N/A
- Fundamental
- Price
- LUCY $1.96
- CELZ $3.23
- Analyst Decision
- LUCY
- CELZ
- Analyst Count
- LUCY 0
- CELZ 0
- Target Price
- LUCY N/A
- CELZ N/A
- AVG Volume (30 Days)
- LUCY 185.8K
- CELZ 242.6K
- Earning Date
- LUCY 08-11-2025
- CELZ 08-12-2025
- Dividend Yield
- LUCY N/A
- CELZ N/A
- EPS Growth
- LUCY N/A
- CELZ N/A
- EPS
- LUCY N/A
- CELZ N/A
- Revenue
- LUCY $1,707,470.00
- CELZ $14,000.00
- Revenue This Year
- LUCY $367.48
- CELZ N/A
- Revenue Next Year
- LUCY $166.67
- CELZ N/A
- P/E Ratio
- LUCY N/A
- CELZ N/A
- Revenue Growth
- LUCY 22.75
- CELZ 55.56
- 52 Week Low
- LUCY $1.57
- CELZ $1.69
- 52 Week High
- LUCY $11.16
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- LUCY 40.17
- CELZ 58.70
- Support Level
- LUCY $1.86
- CELZ $2.64
- Resistance Level
- LUCY $2.16
- CELZ $3.18
- Average True Range (ATR)
- LUCY 0.10
- CELZ 0.19
- MACD
- LUCY -0.00
- CELZ 0.01
- Stochastic Oscillator
- LUCY 22.82
- CELZ 65.68
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.